Lervasen Pillay

Oct 2, 2023 | journals.assaf.org.za | Lervasen Pillay |Jeroen Swart |Sharief Hendricks |Craig Thompson

Cannabidiol (CBD) and Tetrahydrocannabinol (THC) have become easily available to athletes over the years. Using these substances may inadvertently expose an athlete to the possibility of an adverse analytical finding (a ”positive” test) and a sanction. Athletes need to understand the risk of an antidoping rule violation or adverse analytical finding should these products be used, especially if no therapeutic use exemption exists.